Filing Flows

Filing Flows › Zai Lab (ZLAB) › Recalls, complaints & regulation

Zai Lab (ZLAB): clinical trials

Zai Lab (ZLAB) beyond its filings: 9 active clinical trials.

Zai Lab's latest quarter

Zai Lab, Q3 2026: revenue $108M (-7% year over year), operating margin -58.2%, net loss $46.1M, operating cash flow −$57.9M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Zai Lab have?

9 active studies on ClinicalTrials.gov, 3 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.